SynAct Pharma’s SEK 136 Million Acquisition of TXP Pharma

Setterwalls has assisted SynAct Pharma AB in the transaction.SynAct Pharma AB announced the acquisition of the Swiss-incorporated biotech company TXP Pharma AG. The acquisition encompasses all…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Federica Tiefenthaler

Author: Federica Tiefenthaler

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here